Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03363373 |
|---|---|
| Brief Title: | Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow |
| First Submitted : | November 6, 2017 |
| First Submitted that Met QC Criteria : | December 5, 2017 |
| First Posted : | December 6, 2017 |
| Last Update Submitted that Met QC Criteria : | March 6, 2023 |
| Last Update Posted : | March 7, 2023 |